Hanjin KAL, HD Hyundai Marine Solution, and SK Biopharmaceuticals Excluded from MSCI Korea Index
Hanjin KAL, HD Hyundai Marine Solution, and SK Biopharmaceuticals have been excluded from the MSCI Korea Index constituents.
On May 12 (local time), global equity index provider MSCI announced the results of its May regular review, making these adjustments to the Korea Index constituents.
No new stocks have been added. Previously, Rainbow Robotics and others were mentioned as potential candidates for inclusion, but it is reported that they did not meet the requirements for market capitalization and free-float market capitalization. The index rebalancing will take place after the market closes on May 29.
MSCI reviews its indices every February, May, August, and November, adjusting constituent stocks based on total market capitalization and free-float market capitalization. In February, Hyundai Engineering & Construction and Samsung Epis Holdings were newly included, while Coway, Doosan Bobcat, and LG Household & Health Care were excluded.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
The MSCI Index serves as a benchmark for global investors. When a stock is included in the index, global passive funds that track this index flow in. However, when a stock is excluded, capital outflows may occur.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.